Eden Research (LON:EDEN) Shares Up 18.4% – Still a Buy?

Eden Research plc (LON:EDEN) shares were up 18.4% during trading on Tuesday. The company traded as high as GBX 2.90 and last traded at GBX 2.90. 3,891,780 shares were traded during trading, an increase of 598% from the average daily volume of 557,270 shares. The stock had previously closed at GBX 2.45.

Eden Research Stock Up 18.4%

The firm’s 50-day simple moving average is GBX 2.27 and its 200 day simple moving average is GBX 3.05. The company has a debt-to-equity ratio of 5.41, a quick ratio of 2.42 and a current ratio of 1.95. The company has a market cap of £23.30 million, a P/E ratio of -6.54 and a beta of 1.61.

Eden Research (LON:EDEN) last posted its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share (EPS) for the quarter. Eden Research had a negative return on equity of 16.16% and a negative net margin of 50.43%. On average, research analysts forecast that Eden Research plc will post -66.00 earnings per share for the current fiscal year.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.